Literature DB >> 25983449

Current concepts in surgical treatment of osteosarcoma.

Akshay Tiwari1.   

Abstract

Osteosarcoma is the most common malignant primary neoplasm of bone. For an optimal oncological outcome, surgical removal of tumor is an essential component of its multidisciplinary treatment. Limb salvage surgery has long been established as the standard of care for osteosarcoma. While limb-salvaging techniques have acceptable rates of disease control, amputation remains a valid procedure in selected cases. In current orthopedic oncology practice, the focus is on optimizing the balance between preservation of form and function of the limb and adequate oncological clearance at the same time. Improving the functional outcome and longevity of reconstructive procedures also remains a challenge.

Entities:  

Keywords:  Current concepts; Osteosarcoma; Surgical treatment

Year:  2012        PMID: 25983449      PMCID: PMC3872798          DOI: 10.1016/j.jcot.2012.04.004

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  30 in total

1.  Expandable endoprosthesis for limb-sparing surgery in children: long-term results.

Authors:  Amit Dotan; Shlomo Dadia; Jacob Bickels; Alexander Nirkin; Gideon Flusser; Josephin Issakov; Yoram Neumann; Ian Cohen; Myriam Ben-Arush; Yehuda Kollender; Isaac Meller
Journal:  J Child Orthop       Date:  2010-07-22       Impact factor: 1.548

2.  Local recurrence has only a small effect on survival in high-risk extremity osteosarcoma.

Authors:  Chang-Bae Kong; Won Seok Song; Wan Hyeong Cho; Jung Moon Oh; Dae-Geun Jeon
Journal:  Clin Orthop Relat Res       Date:  2011-10-19       Impact factor: 4.176

3.  The cost-effectiveness of limb salvage for bone tumours.

Authors:  R J Grimer; S R Carter; P B Pynsent
Journal:  J Bone Joint Surg Br       Date:  1997-07

4.  Osteosarcoma.

Authors:  R Sweetnam
Journal:  Br Med J       Date:  1979-09-01

5.  New method of evaluating the surgical margin and safety margin for musculoskeletal sarcoma, analysed on the basis of 457 surgical cases.

Authors:  N Kawaguchi; S Matumoto; J Manabe
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 6.  Infection following bone tumor resection and reconstruction with tumoral prostheses: a literature review.

Authors:  C Graci; G Maccauro; F Muratori; M S Spinelli; M A Rosa; C Fabbriciani
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Oct-Dec       Impact factor: 3.219

7.  MRI-guided navigation surgery with temporary implantable bone markers in limb salvage for sarcoma.

Authors:  June Hyuk Kim; Hyun Guy Kang; Han-Soo Kim
Journal:  Clin Orthop Relat Res       Date:  2010-01-07       Impact factor: 4.176

8.  Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study.

Authors:  B T Rougraff; M A Simon; J S Kneisl; D B Greenberg; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1994-05       Impact factor: 5.284

9.  Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.

Authors:  Allen M Goorin; Douglas J Schwartzentruber; Meenakshi Devidas; Mark C Gebhardt; Alberto G Ayala; Michael B Harris; Lee J Helman; Holcombe E Grier; Michael P Link
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

10.  Prognostic factors in pulmonary metastasized high-grade osteosarcoma.

Authors:  Emilie P Buddingh; Jakob K Anninga; Michel I M Versteegh; Antonie H M Taminiau; R Maarten Egeler; Catherina S P van Rijswijk; Pancras C W Hogendoorn; Arjan C Lankester; Hans Gelderblom
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

View more
  8 in total

1.  Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement.

Authors:  Kyoung Jin Chang; Chang-Bae Kong; Wan Hyeong Cho; Dae-Geun Jeon; Soo-Yong Lee; Ilhan Lim; Sang Moo Lim
Journal:  Skeletal Radiol       Date:  2014-11-29       Impact factor: 2.199

Review 2.  Reverse shoulder arthroplasty after failed megaprosthesis for osteosarcoma of the proximal humerus: A case report and review of literature.

Authors:  V Singh Chauhan; Abhishek Vaish; Raju Vaishya
Journal:  J Clin Orthop Trauma       Date:  2019-03-22

3.  Nickel-titanium shape memory alloy embracing fixator benefits the determination of the implantation angle of prosthesis stem in tumor-type artificial joint replacement.

Authors:  Yang Wang; Hongrui Wang; Hongyue Zhang; Wei Miao; Jilu Liu; Shuogui Xu
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

Review 4.  Limb Salvage and Reconstruction Options in Osteosarcoma.

Authors:  Samuel Z Grinberg; Abigail Posta; Kristy L Weber; Robert J Wilson
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 5.  A review and outlook in the treatment of osteosarcoma and other deep tumors with photodynamic therapy: from basic to deep.

Authors:  Wei Yu; Jian Zhu; Yitian Wang; Junjie Wang; Weijing Fang; Kaishun Xia; Jianlin Shao; Minzu Wu; Bing Liu; Chengzhen Liang; Chengyi Ye; Huimin Tao
Journal:  Oncotarget       Date:  2017-06-13

Review 6.  Extracellular Vesicles in Osteosarcoma: Antagonists or Therapeutic Agents?

Authors:  Viviana De Martino; Michela Rossi; Giulia Battafarano; Jessica Pepe; Salvatore Minisola; Andrea Del Fattore
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

7.  Clinical value of ultrasound for the evaluation of local recurrence of primary bone tumors.

Authors:  Yu Wang; Ping Yu; Feifei Liu; Yuqin Wang; Jiaan Zhu
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

8.  Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.

Authors:  Wangdong Jin; Li Zhou; Bo Yan; Li Yan; Fucun Liu; Peijian Tong; Wenhua Yu; Xiaoqiao Dong; Li Xie; Jin Zhang; Yiqiao Xu; Chunqi Li; Qiang Yuan; Letian Shan; Thomas Efferth
Journal:  J Cell Mol Med       Date:  2018-07-11       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.